Phreesia Inc
NYSE:PHR
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
14.75
28.86
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one PHR stock under the Base Case scenario is 18.35 USD. Compared to the current market price of 21.63 USD, Phreesia Inc is Overvalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Phreesia Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for PHR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Phreesia Inc
Balance Sheet Decomposition
Phreesia Inc
Current Assets | 180.9m |
Cash & Short-Term Investments | 81.8m |
Receivables | 86.6m |
Other Current Assets | 12.5m |
Non-Current Assets | 181.3m |
PP&E | 22.8m |
Intangibles | 155.5m |
Other Non-Current Assets | 3m |
Current Liabilities | 102m |
Accounts Payable | 7m |
Accrued Liabilities | 31.7m |
Other Current Liabilities | 63.4m |
Non-Current Liabilities | 8.9m |
Long-Term Debt | 7.3m |
Other Non-Current Liabilities | 1.6m |
Earnings Waterfall
Phreesia Inc
Revenue
|
390m
USD
|
Cost of Revenue
|
-129.5m
USD
|
Gross Profit
|
260.4m
USD
|
Operating Expenses
|
-359.8m
USD
|
Operating Income
|
-99.4m
USD
|
Other Expenses
|
-938k
USD
|
Net Income
|
-100.3m
USD
|
Free Cash Flow Analysis
Phreesia Inc
USD | |
Free Cash Flow | USD |
Phreesia has reached positive free cash flow for the first time as a public company, marking a significant milestone. For Q2 fiscal 2025, the company reported revenue of $102.1 million, up 19% year-over-year. Adjusted EBITDA rose to $6.5 million. Operating cash flow hit $11.1 million, and free cash flow was $3.7 million. Phreesia maintains its FY2025 revenue outlook between $416 million to $426 million and raises its adjusted EBITDA forecast to $26 million-$31 million. The company anticipates average healthcare service clients (AHSC) of around 4,200, with revenue per AHSC expected to increase compared to fiscal 2024.
What is Earnings Call?
PHR Profitability Score
Profitability Due Diligence
Phreesia Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
Score
Phreesia Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
PHR Solvency Score
Solvency Due Diligence
Phreesia Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
Phreesia Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PHR Price Targets Summary
Phreesia Inc
According to Wall Street analysts, the average 1-year price target for PHR is 30.02 USD with a low forecast of 23.23 USD and a high forecast of 35.7 USD.
Dividends
Current shareholder yield for PHR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
PHR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Phreesia, Inc. is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The company is headquartered in Raleigh, North Carolina and currently employs 1,701 full-time employees. The company went IPO on 2019-07-18. The firm offers software-as-a-service (SaaS) based technology platform, namely Phreesia Platform, which offers healthcare services clients with a suite of integrated solutions that manage patient access, registration, payments and clinical support. Its platform operates as a single, unified, multi-tenant platform that has demonstrated scalability and seamless integration within the operating infrastructure of its healthcare services clients. The Company’s platform offers various solutions to its clients, which includes appointments, registration, revenue cycle, clinical support, COVID-19 product offerings, patient activation and life sciences solutions. The company serves an array of provider clients ranging from single-specialty practices, which include internal and family medicine, urology, dermatology, and orthopedics to multi-specialty groups and health systems, as well as regional and national payers and other organizations.
Contact
IPO
Employees
Officers
The intrinsic value of one PHR stock under the Base Case scenario is 18.35 USD.
Compared to the current market price of 21.63 USD, Phreesia Inc is Overvalued by 15%.